tyme technologies stock price target
45 rows TYME has a less variance in analysts estimates than nearly 100 of all US stocks. Find the latest Tyme Technologies Inc TYME stock price forecast 12-month price target predictions and analyst recommendations.
Tyme Technologies Nasdaq Tyme Is In A Good Position To Deliver On Growth Plans Nasdaq
Stay up to date on the latest stock price chart news analysis fundamentals trading and investment tools.
. The Tyme Technologies stock price prediction module provides an analysis of price elasticity to changes in media outlook on Tyme Technologies over a specific investment horizon. 6558 of MarketBeat users gave Tyme Technologies an outperform vote while medical companies recieve an average of 6719. Find the latest analyst research for Tyme Technologies Inc.
TYME updated stock price target summary. Analyst ratings historical stock prices earnings estimates actuals. Do note that if the stock price manages to stay at current levels or higher our prediction target will start to change.
TYME Delayed Price USD. TYME Stock Trend. The average TYME TECHNOLOGIES stock price prediction forecasts a potential upside of from the current TYME share price of 024.
Tyme Technologies current and average target prices are 035 and 883 respectively. Find the latest Tyme Technologies Inc. The average price target is 000 with a high forecast of 000 and a low forecast of 000.
Real-time trade and investing ideas on Tyme Technologies Inc TYME from the largest community of traders and investors. 1 month ago - Market Watch. Get the latest Tyme Technologies Inc TYME detailed stock.
The 1 analysts offering 12-month price forecasts for Tyme Technologies Inc have a median target of 800 with a high estimate of. Find the latest Tyme Technologies Inc. TYME stock quote history news and other vital information to help you with your stock trading and investing.
Volume has increased on the last day by 242. For ratings consensus and a summary of stock price. The Tyme Technologies Inc stock price fell by -880 on the last day Tuesday 24th May 2022 from 027 to 024.
Rooms Shows Rankings Earnings Newsletters Shop. Stock information by Barrons. Complete Tyme Technologies Inc.
Get the latest Tyme Technologies stock price and detailed information including TYME news historical charts and realtime prices. TYME -556 a biotech developing cancer metabolism-based treatments said Tuesday its board has decided to explore its strategic options and has hired Moelis Co. View Tyme Technologies Inc TYME investment stock information.
The current price of Tyme Technologies is the price at which Tyme Technologies is currently trading. Tyme Technologies Target Price Projection. The average price target is 95 which means analysts expect the stock to rise by 60370 over the next twelve months.
The average price target is 000 with a high estimate of. View real-time TYME stock price and news along with industry-best analysis. Tyme Technologies shares jump premarket on news board to explore strategic options.
On average analysts give Tyme Technologies Inc a Strong Buy rating. On average analysts rate TYME. The lowest target is 96 and the highest is 998.
Tyme Technologies Inc 026 002 766 Watch. Tyme Technologies Inc. According to 7 stock analysts the average 12-month stock price forecast for TYME stock is 969 which predicts an increase of 362692.
What is TYMEs Earnings Per Share EPS forecast for 2023-2025. 1 Wall Street analyst that have issued a 1 year TYME price target the average TYME price target is 950. Band Projection param Lower.
MarketBeat users like Tyme Technologies stock less than the stock of other Medical companies. Tyme Technologies Price Target Predictions Analyst Ratings 026-001 -185 As of 05232022 0121 PM ET. The average price target represents a -10000 upside from the last price of 027.
This chart shows the closing price for TYME for the. A high-level overview of Tyme Technologies Inc. On the other hand Tyme Technologies target price is what analysts think the stock is worth or could sell for in.
That average ranking earns Tyme Technologies Inc an Analyst Rating of 79 which is better than 79 of stocks based on data compiled by InvestorsObserver. Given the current short-term trend the stock is expected to fall -5860 during the next 3 months and with a 90 probability hold a price between 00656 and 014 at the end of this 3-month period. And has now fallen 3 days in a rowDuring the day the stock fluctuated 986 from a day low at 024 to a day high of 027The price has risen in 6 of the last 10 days but is still down by -766 for this period.
TYME analyst stock forecast price target and recommendation trends with in-depth analysis from research. This price target is based on 0 analysts offering 12 month price targets for Tyme Technologies in the last 3 months.
Tyme Technologies Reviews Potential Strategic Options
Tyme Technologies Price Target Analyst Ratings Nasdaq Tyme
Tyme Technologies Inc Home Facebook
Tyme Technologies My Bamboo Speculation In A Potential Leader In Cancer Metabolism Based Therapies Nasdaq Tyme Seeking Alpha
Is Tyme Technologies Inc Tyme Going To Burn These Hedge Funds
What You Need To Know Before Buying Tyme Technologies Inc Nasdaq Tyme Stock
Should You Buy Tyme Stock
Is Tyme Technologies Inc S Nasdaq Tyme Shareholder Ownership Skewed Towards Insiders
As Tyme Technologies Inc S Nasdaq Tyme Market Cap Dropped By Us 12m Insiders Who Sold Us 1 3m Worth Of Stock Were Able To Offset Their Losses Simply Wall St News
Tyme Technologies Inc Nasdaq Tyme Major Shareholder Michael Demurjian Sells 50 000 Shares Defense World
We Re Keeping An Eye On Tyme Technologies Nasdaq Tyme Cash Burn Rate
Tyme Technologies Debating An Investment After Recent Sm 88 Update Nasdaq Tyme Seeking Alpha
Tyme Technologies Nasdaqcm Tyme Share Price News Analysis Simply Wall St
Is Tyme Technologies Inc S Nasdaq Tyme Shareholder Ownership Skewed Towards Insiders
Tyme Technologies Inc Big Range Breakout And Next Big Target Tyme Stock Breakouts Tyme Global Economy
Tyme Technologies Inc Share Price Usd0 0001
18qyx0zco2azmm
Tyme Technologies My Bamboo Speculation In A Potential Leader In Cancer Metabolism Based Therapies Nasdaq Tyme Seeking Alpha
Revisiting Tyme Technologies Nasdaq Tyme Seeking Alpha